Summit Hotel Properties, Inc. (INN) News
Filter INN News Items
INN News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest INN News From Around the Web
Below are the latest news stories about SUMMIT HOTEL PROPERTIES INC that investors may wish to consider to help them evaluate INN as an investment opportunity.
Innocan Pharma Announces Promising LPT-CBD Safety Indications -Implications from a prolong use in animalsInnocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce the company's latest groundbreaking findings. |
Summit Hotel Properties, Inc. (NYSE:INN) Q3 2023 Earnings Call TranscriptSummit Hotel Properties, Inc. (NYSE:INN) Q3 2023 Earnings Call Transcript November 2, 2023 Operator: Good day and thank you for standing by. Welcome to the Summit Hotel Properties Q3 2023 Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I’d now like to hand the conference over to your speaker […] |
Q3 2023 Summit Hotel Properties Inc Earnings CallQ3 2023 Summit Hotel Properties Inc Earnings Call |
Here's What Key Metrics Tell Us About Summit Hotel Properties (INN) Q3 EarningsThe headline numbers for Summit Hotel Properties (INN) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. |
SUMMIT HOTEL PROPERTIES REPORTS THIRD QUARTER 2023 RESULTSSummit Hotel Properties, Inc. (NYSE: INN) (the "Company"), today announced results for the three and nine months ended September 30, 2023. |
Pebblebrook Hotel (PEB) Beats Q3 FFO and Revenue EstimatesPebblebrook Hotel (PEB) delivered FFO and revenue surprises of 7.02% and 1.25%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock? |
SUMMIT HOTEL PROPERTIES DECLARES THIRD QUARTER 2023 DIVIDENDSSummit Hotel Properties, Inc. (NYSE: INN) (the "Company"), announced today that its Board of Directors has authorized, and the Company has declared, a cash dividend for the third quarter ended September 30, 2023, of $0.06 per share of common stock of the Company and per common unit of limited partnership interest in Summit Hotel OP, LP, the Company's operating partnership. The Company's third quarter common dividend represents an annualized dividend yield of 4.3 percent based on the closing pric |
Innocan Pharma reports a groundbreaking discovery regarding its LPD platform and global CBD researchInnocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce the company's latest groundbreaking findings. Research over the past several months has identified animals that metabolize cannabidiol (CBD), administered as a liposomal CBD injection, in a manner similar to humans. This means that results related to LPT-CBD metabolism obtained from experiments with these types of anim |
Innocan Pharma Announces Closing of Second and Final Tranche of FinancingInnocan Pharma Corporation ("Innocan" or the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that it has closed the second and final tranche (the "Second Tranche") of its previously announced private placement offering (the "Offering") of units of the Company (the "Units"), pursuant to which the Company issued 4,005,408 Units at a price of $0.30 per Unit (the "Offering Price") for aggregate gross proceeds of $1,201,622.40. In total, the Company issued an aggregate of 5,42 |
Innocan Pharma Announces Closing of First Tranche Private Placement and Provides Corporate UpdateInnocan Pharma Corporation (the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that it has closed the first of two tranches (the "First Tranche") of its previously announced private placement offering (the "Offering") of units of the Company (the "Units"), pursuant to which the Company issued 1,420,200 Units at a price of $0.30 per Unit (the "Offering Price") for aggregate gross proceeds of $426,060. The Company expects to complete a second and final tranche of the Offer |